The U.S. Cybersecurity and Infrastructure Security Agency (CISA) recently issued a warning of the risk of Russian cyberattacks spilling over onto United States networks as part of the Russian invasion of Ukraine. This follows previous CISA warnings on the risks posed by Russian cyberattacks for critical infrastructure. The European Central Bank (ECB) has similarly warned European financial institutions of the risk of Russian cyberattacks and related market disruptions.
The risk of cyberattacks is forcing businesses and insurers to examine their policies to determine which coverages may apply to losses caused by a cyberattack. The current elevated risk draws into focus the recent decision in Merck and International Indemnity v. ACE (et al.), in which the Superior Court of New Jersey examined coverage under an All-Risk insurance policy for loss arising from the NotPetya malware. NotPetya was allegedly used by Russia in a cyberattack on Ukraine and spilled over into the rest of the world. The Merck court found that the "Hostile/Warlike action" exclusion contained in the subject policy was inapplicable and could not be used to exclude coverage for the loss.
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Thought leadership on regulatory changes, economic trends, corporate success stories, and tactical solutions for treasurers, CFOs, risk managers, controllers, and other finance professionals
- Informative weekly newsletter featuring news, analysis, real-world case studies, and other critical content
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.